Clinical trial

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

NCT04229303

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2020-02-11

PhasePHASE1

Study timeline

Study start (actual)2020-02-11Date precision: day

Registry last updated2021-11-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Allergic Bronchopulmonary Aspergillosisunresolved

Interventions

Voriconazole inhaledDRUG

oral voriconazoleDRUG

Sponsors & collaborators

Zambon SpAlead sponsor

Mapped research locations

ManchesterUnited Kingdom1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04229303 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.